1 3ml vial of Semaglutide 30mg
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has gained significant attention in metabolic research for its profound effects on appetite regulation, glycemic control, and body composition. Originally developed for Type 2 diabetes, it is now extensively studied for its potential in supporting fat loss and metabolic health.
This 30mg presentation offers a higher-yield format for extended research protocols and may support investigators exploring long-term outcomes in appetite suppression, insulin sensitivity, and energy expenditure. Semaglutide’s mechanism includes delayed gastric emptying, enhanced insulin secretion (glucose-dependent), and modulation of satiety signals in the brain—making it a key subject in obesity and weight management studies.
Important Notice
This product is intended for research and laboratory use only. It is not approved for human or veterinary use, nor for diagnostic or therapeutic applications. Always handle with appropriate safety measures and comply with all relevant laws and regulations.